D. Bello-Roufai

Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma

B. Chauffert, N. Etienne-Selloum, L. Choulier, 2021, Pharmaceuticals.

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study

B. Chauffert, N. Etienne-Selloum, G. Ahle, 2019, Journal of Neuro-Oncology.

Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).

C. Genestie, D. Berton, I. Ray-Coquard, 2020, Gynecologic oncology.

Phase III MIRASOL (GOG 3045/ENGOT-ov55) study: Initial report of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in platinum-resistant, advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression.

A. Berkenblit, S. Pignata, Susana Banerjee, 2023, Journal of Clinical Oncology.